Welcome to the next Cancer Core Europe (CCE) Lecture, hosted by the University of Cambridge and the Cancer Research UK Cambridge Centre.
The Partner Trial: Developing Precision Medicine for Hereditary & Triple Negative Breast Cancer
Speaker: Jean Abraham, Professor of Precision Breast Cancer Medicine and Honorary Consultant in Medical Oncology
Monday, 18th November - Time: 16:00 CET / 15:00 UK
Zoom link: https://us02web.zoom.us/j/87629305887?pwd=Ha5mJ79eck91IXBCHJBoJfwlZbDy9Z.1#success
Jean Abraham is Professor of Precision Breast Cancer Medicine and an Honorary Consultant in Medical Oncology at the University of Cambridge. She directs the Precision Breast Cancer Institute, University of Cambridge, and co-leads the Integrated Cancer Medicine theme and the Breast Cancer Virtual Institute in the Cancer Research UK Cambridge Centre. Jean is deputy theme lead for Cancer at the Cambridge NIHR Biomedical Research Centre.
What is Cancer Core Europe (CCE)?
Cancer Core Europe is a consortium of seven leading cancer centres (www.cancercoreeurope.eu). CCEs members are driven by a strong will to reshape the cancer research model to ultimately increase the European Union’s competitiveness as a place to conduct cutting-edge research that’s translated to the clinic to deliver more personalized medicine.
What is the content and aim of the CCE Lecture?
The CCE Lecture series is a CCE-internal event, which educates and informs about state-of-the-art research within the seven centers and is aimed to increase awareness among partners about each other’s activities and potential for collaboration.
